Kaletra
(2S)-N-[(2S,4S,5S)-5-[[2-(2,6-dimethylphenoxy)acetyl]amino]-4-hydroxy-1,6-diphenylhexan-2-yl]-3-methyl-2-(2-oxo-1,3-diazinan-1-yl)butanamide;1,3-thiazol-5-ylmethyl N-[(2S,3S,5S)-3-hydroxy-5-[[(2S)-3-methyl-2-[[methyl-[(2-propan-2-yl-1,3-thiazol-4-yl)methyl]carbamoyl]amino]butanoyl]amino]-1,6-diphenylhexan-2-yl]carbamate
Molecular Identity
Kaletra
(2S)-N-[(2S,4S,5S)-5-[[2-(2,6-dimethylphenoxy)acetyl]amino]-4-hydroxy-1,6-diphenylhexan-2-yl]-3-methyl-2-(2-oxo-1,3-diazinan-1-yl)butanamide;1,3-thiazol-5-ylmethyl N-[(2S,3S,5S)-3-hydroxy-5-[[(2S)-3-methyl-2-[[methyl-[(2-propan-2-yl-1,3-thiazol-4-yl)methyl]carbamoyl]amino]butanoyl]amino]-1,6-diphenylhexan-2-yl]carbamate
PubChem CID: 11979606
Kaletra is a mixture containing lopinavir and ritonavir. It is a prescription medicine that is used with other antiretroviral medicines to treat Human Immunodeficiency Virus-1 (HIV-1) infection in adults and children 14 days of age and older. It has a role as an anticoronaviral agent, a HIV protease inhibitor and an antiviral drug. It contains a lopinavir and a ritonavir.
2D Structure
Properties
C74H96N10O10S2
Molecular Formula
1349.70
Molecular Weight
g/mol
1348.6752
Exact Mass
Da
322
TPSA
May have limited oral absorption
8
H-Bond Donors
14
H-Bond Acceptors
1980
Complexity
SMILES
Canonical SMILES
SMILES: Synonyms(20)
KaletraLopinavir/RitonavirLopinavir and ritonavirlopinavir-ritonavirCHEBI:145924Lopinavir + ritonavirRefChem:56940LOPINAVIR; RITONAVIRAluviaLPV/rLopinavir-Ritonavir mixt369372-47-4Ritonavir-boosted lopinavirLopinavir & RitonavirABT-378 & ABT-538
Data from PubChem (NCBI)
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Drug Network
Trials and conditions connected to Kaletra
Loading drug network...